Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
10.37
+0.06 (0.58%)
Oct 21, 2025, 3:28 PM EDT - Market open
Viatris Market Cap
Viatris has a market cap or net worth of $12.09 billion as of October 21, 2025. Its market cap has decreased by -11.38% in one year.
Market Cap
12.09B
Enterprise Value
26.17B
1-Year Change
-11.38%
Ranking
Category
Stock Price
$10.37
Market Cap Chart
Since May 15, 1984, Viatris's market cap has increased from $146.99M to $12.09B, an increase of 8,125.21%. That is a compound annual growth rate of 11.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 12.02B | -19.11% |
| Dec 31, 2024 | 14.86B | 14.38% |
| Dec 29, 2023 | 12.99B | -3.74% |
| Dec 30, 2022 | 13.50B | -17.51% |
| Dec 31, 2021 | 16.36B | -27.24% |
| Dec 31, 2020 | 22.49B | 116.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.40B |
| Johnson & Johnson | 464.93B |
| AbbVie | 409.10B |
| UnitedHealth Group | 333.52B |
| AstraZeneca | 261.56B |
| Novartis AG | 254.74B |
| Novo Nordisk | 249.65B |
| Abbott Laboratories | 223.65B |